Plain-English translation of NCT07293832 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
After a heart attack, the research team wants to know if landiolol—a medication that helps control the heart's stress response—can reduce the amount of heart tissue that dies if given very early. Right now, doctors aren't certain whether this medication truly helps when given through an IV immediately after a heart attack. This study will compare patients who receive this medication with those who get standard heart medication by mouth.
When a heart attack happens, the heart is under enormous stress, and that stress can actually increase the amount of damage. Doctors think this medication might protect the heart during this critical time, but they need to study it carefully to be sure it truly helps.
You likely qualify if…
You likely don't qualify if…
If you join this study, your cardiologist will decide whether you receive the medication through an IV or take standard oral heart medication during your hospital stay. You will have heart imaging tests done during hospitalization and at least three months later to measure how much heart damage occurred. You'll also have blood tests, heart rhythm monitoring, and an ultrasound of your heart to assess how well it's pumping.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
Greece